Will Ozempic be ranked within the top three prescribed drugs for diabetes by June 30, 2024?
Plus
20
Ṁ21kJun 21
2%
chance
1D
1W
1M
ALL
This market resolves to 'yes' if market reports or pharmaceutical tracking studies published by IQVIA, the National Prescription Audit (NPA), or the Centers for Medicare & Medicaid Services (CMS) before or on June 30, 2024, rank Ozempic among the top three prescribed drugs for diabetes. The resolution source will be the publicly available reports from these specified organizations. The market end date is June 30, 2024.
This question is managed and resolved by Manifold.
Get
1,000and
3.00
1,0003.00Related questions
Related questions
Will Ozempic be FDA approved for use in type 1 diabetes patients by end of 2024?
11% chance
Will Pfizer announce a weight loss drug competing with Ozempic and Wygovy before 12/31/2024?
35% chance
Will Kim Jong Un start taking Ozempic (or any GLP-1) by the end of 2025?
36% chance
How much will Ozempic cost in 2027 in the USA?
Will Ozempic / semaglutide be FDA-approved for Alzheimer's before 2030?
58% chance
Will a clinical trial reporting weight-loss benefits of a GLP-1 agonist be published in a major medical journal in 2024?
75% chance
Will Ozempic/GLP-1 Agonists become an issue with a clear partisan divide in the US in the next 5 years?
39% chance
What will happen to the GLP-1 / Ozempic compounding pharmacy loophole?
The FDA will warn about overuse or misuse of semaglutide (Ozempic, Wegovy and Rybelsus) before the end of 2024.
19% chance
Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?
30% chance